These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16997706)

  • 1. Physiologic characterisation of glioblastoma multiforme using MRI-based hypoxia mapping, chemical shift imaging, perfusion and diffusion maps.
    McMillan KM; Rogers BP; Field AS; Laird AR; Fine JP; Meyerand ME
    J Clin Neurosci; 2006 Oct; 13(8):811-7. PubMed ID: 16997706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
    Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
    J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
    Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
    AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
    Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab.
    Ellingson BM; Cloughesy TF; Lai A; Nghiemphu PL; Pope WB
    Magn Reson Med; 2012 Jan; 67(1):237-45. PubMed ID: 21702063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.
    Takano S; Kimu H; Tsuda K; Osuka S; Nakai K; Yamamoto T; Ishikawa E; Akutsu H; Matsuda M; Matsumura A
    Acta Neurochir Suppl; 2013; 118():185-9. PubMed ID: 23564129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An objective method for combining multi-parametric MRI datasets to characterize malignant tumors.
    McMillan KM; Rogers BP; Koay CG; Laird AR; Price RR; Meyerand ME
    Med Phys; 2007 Mar; 34(3):1053-61. PubMed ID: 17441252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma.
    Awasthi R; Verma SK; Haris M; Singh A; Behari S; Jaiswal AK; Rajput D; Pandey R; Rathore RK; Pandey CM; Gupta RK
    J Comput Assist Tomogr; 2010 Jan; 34(1):82-8. PubMed ID: 20118727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.
    Hu X; Wong KK; Young GS; Guo L; Wong ST
    J Magn Reson Imaging; 2011 Feb; 33(2):296-305. PubMed ID: 21274970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping.
    Ulmer S; Hartwigsen G; Riedel C; Jansen O; Mehdorn HM; Nabavi A
    Neuroimage; 2010 Feb; 49(3):2158-62. PubMed ID: 19900562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
    AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
    Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
    Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
    Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
    Gasparetto EL; Pawlak MA; Patel SH; Huse J; Woo JH; Krejza J; Rosenfeld MR; O'Rourke DM; Lustig R; Melhem ER; Wolf RL
    Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.